Ivonescimab 20 mg/kg

DRUG2 trials

Sponsors

PrECOG, LLC., National University Hospital, Singapore

Conditions

Extensive Stage Lung Small Cell CancerNasopharyngeal Carcinoma (NPC)

Phase 2

Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer

RecruitingNCT07057791

PrECOG, LLC.Extensive Stage Lung Small Cell Cancer

Start: 2026-03-30End: 2030-01-01Target: 60Updated: 2026-05-14

Evaluating Ivonescimab in PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma

Not yet recruitingNCT07565389

National University Hospital, SingaporeNasopharyngeal Carcinoma (NPC)

Start: 2026-05-01End: 2031-05-01Target: 42Updated: 2026-05-04